# PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

> **NCT03594760** · PHASE3 · RECRUITING · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 1000 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 18F-DCFPyL IV injection

## Key facts

- **NCT ID:** NCT03594760
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-12-01
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594760, "PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03594760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*